enGene Therapeutics Inc. (ENGN) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $50.15M | -71.0% |
| 2024 | $173.00M | +112.2% |
| 2023 | $81.52M | +298.9% |
| 2022 | $20.43M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $50.15M | -71.0% |
| 2024 | $173.00M | +112.2% |
| 2023 | $81.52M | +298.9% |
| 2022 | $20.43M | — |